交易 Phathom Pharmaceuticals, Inc. - PHAT CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.06 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Phathom Pharmaceuticals Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 27, 2024 | 11.02 | 0.72 | 6.99% | 10.30 | 11.11 | 10.17 |
Mar 26, 2024 | 10.46 | -0.19 | -1.78% | 10.65 | 11.36 | 10.40 |
Mar 25, 2024 | 10.41 | -0.76 | -6.80% | 11.17 | 11.30 | 10.19 |
Mar 22, 2024 | 10.98 | 1.89 | 20.79% | 9.09 | 11.37 | 9.09 |
Mar 21, 2024 | 9.11 | 0.13 | 1.45% | 8.98 | 9.81 | 8.98 |
Mar 20, 2024 | 9.10 | 0.57 | 6.68% | 8.53 | 9.16 | 8.46 |
Mar 19, 2024 | 8.59 | 0.56 | 6.97% | 8.03 | 8.77 | 8.03 |
Mar 18, 2024 | 8.24 | -0.14 | -1.67% | 8.38 | 8.48 | 8.08 |
Mar 15, 2024 | 8.46 | 0.69 | 8.88% | 7.77 | 8.47 | 7.77 |
Mar 14, 2024 | 7.74 | -0.09 | -1.15% | 7.83 | 7.89 | 7.53 |
Mar 13, 2024 | 7.96 | -0.02 | -0.25% | 7.98 | 8.30 | 7.94 |
Mar 12, 2024 | 8.13 | -0.13 | -1.57% | 8.26 | 8.43 | 7.85 |
Mar 11, 2024 | 8.22 | -0.66 | -7.43% | 8.88 | 9.00 | 8.18 |
Mar 8, 2024 | 8.85 | -0.22 | -2.43% | 9.07 | 9.20 | 8.55 |
Mar 7, 2024 | 9.05 | -1.15 | -11.27% | 10.20 | 10.20 | 8.55 |
Mar 6, 2024 | 9.69 | -0.17 | -1.72% | 9.86 | 9.94 | 9.18 |
Mar 5, 2024 | 9.89 | -0.17 | -1.69% | 10.06 | 10.33 | 9.86 |
Mar 4, 2024 | 10.27 | -0.40 | -3.75% | 10.67 | 10.68 | 10.18 |
Mar 1, 2024 | 10.65 | 0.22 | 2.11% | 10.43 | 10.87 | 10.43 |
Feb 29, 2024 | 10.67 | -0.16 | -1.48% | 10.83 | 11.00 | 10.28 |
Phathom Pharmaceuticals, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Wednesday, May 8, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 Phathom Pharmaceuticals Inc Earnings Release Q1 2024 Phathom Pharmaceuticals Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, May 24, 2024 | ||
時間 (UTC) 15:30 | 國家 US
| 事件 Phathom Pharmaceuticals Inc Annual Shareholders Meeting Phathom Pharmaceuticals Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 172.44 | 137.08 | 125.665 | 106.215 | 1.225 |
銷售/一般/行政費用,總計 | 100.999 | 62.742 | 27.517 | 6.944 | 1.205 |
研究與開發 | 71.441 | 72.338 | 98.148 | 99.271 | 0.02 |
營業收入 | -172.44 | -137.08 | -125.665 | -106.215 | -1.225 |
利息收入(費用),非經營淨值 | -25.173 | -6.747 | -3.49 | -3.088 | -0.013 |
其他,淨值 | -0.11 | -0.056 | 0.087 | -145.828 | -0.05 |
稅前淨收入 | -197.723 | -143.883 | -129.068 | -255.131 | -1.288 |
稅後淨收入 | -197.723 | -143.883 | -129.068 | -255.131 | -1.288 |
未計算非常項目前的淨收益 | -197.723 | -143.883 | -129.068 | -255.131 | -1.288 |
淨收入 | -197.723 | -143.883 | -129.068 | -255.131 | -1.288 |
普通股股東可獲收益 (不含非經常性項目) | -197.723 | -143.883 | -129.068 | -255.131 | -1.288 |
普通股股東可獲收益 (含非經常性項目) | -197.723 | -143.883 | -129.068 | -255.131 | -1.288 |
攤薄淨收入 | -197.723 | -143.883 | -129.068 | -255.131 | -1.288 |
攤薄後加權平均股 | 39.1182 | 30.5112 | 33.2282 | 24.7283 | 25.8835 |
扣除特別項目的每股攤薄盈利 | -5.0545 | -4.71574 | -3.8843 | -10.3174 | -0.04976 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
每股正常攤薄盈利 | -5.0545 | -4.65019 | -3.8843 | -10.3174 | -0.04976 |
異常費用(收入) | 2 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 31.701 | 30.077 | 46.642 | 42.529 | 45.363 |
銷售/一般/行政費用,總計 | 18.937 | 18.598 | 30.696 | 23.509 | 26.548 |
研究與開發 | 12.764 | 11.479 | 15.946 | 19.02 | 18.815 |
營業收入 | -31.701 | -30.077 | -46.642 | -42.529 | -45.363 |
利息收入(費用),非經營淨值 | -9.267 | -7.757 | -8.315 | -8.551 | -5.555 |
其他,淨值 | 0.003 | 0.02 | -0.09 | -0.011 | -0.002 |
稅前淨收入 | -40.965 | -37.814 | -55.047 | -51.091 | -50.92 |
稅後淨收入 | -40.965 | -37.814 | -55.047 | -51.091 | -50.92 |
未計算非常項目前的淨收益 | -40.965 | -37.814 | -55.047 | -51.091 | -50.92 |
淨收入 | -40.965 | -37.814 | -55.047 | -51.091 | -50.92 |
普通股股東可獲收益 (不含非經常性項目) | -40.965 | -37.814 | -55.047 | -51.091 | -50.92 |
普通股股東可獲收益 (含非經常性項目) | -40.965 | -37.814 | -55.047 | -51.091 | -50.92 |
攤薄淨收入 | -40.965 | -37.814 | -55.047 | -51.091 | -50.92 |
攤薄後加權平均股 | 48.5005 | 42.3545 | 41.335 | 38.8203 | 38.272 |
扣除特別項目的每股攤薄盈利 | -0.84463 | -0.8928 | -1.33173 | -1.31609 | -1.33048 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.84463 | -0.8928 | -1.33173 | -1.31609 | -1.33048 |
異常費用(收入) |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 160.512 | 186.526 | 291.368 | 255.601 | 0.902 |
現金和短期投資 | 155.385 | 183.259 | 287.496 | 243.765 | 0.879 |
現金等價物 | 155.385 | 183.259 | 287.496 | 243.765 | 0.879 |
預付的費用 | 5.127 | 3.267 | 3.872 | 11.836 | 0.023 |
總資産 | 164.81 | 189.431 | 295.111 | 257.178 | 0.902 |
其他長期資産,總計 | 0.804 | 0.341 | 0.384 | 0.181 | 0 |
流動負債總額 | 26.237 | 18.921 | 55.524 | 3.748 | 2.188 |
應付賬款 | 9.997 | 5.15 | 16.782 | 0.699 | 0.055 |
預提費用 | 16.24 | 13.771 | 31.389 | 2.636 | 0.183 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 1.95 |
其他流動負債,總計 | 0.413 | 0 | |||
負債總額 | 239.624 | 117.275 | 100.84 | 29.223 | 2.188 |
長期債務總額 | 204.789 | 89.671 | 39.634 | 22.777 | 0 |
長期債務 | 204.789 | 89.671 | 39.634 | 22.777 | 0 |
其他負債,總計 | 8.598 | 8.683 | 5.682 | 2.698 | 0 |
股權 | -74.814 | 72.156 | 194.271 | 227.955 | -1.286 |
普通股 | 0.003 | 0.003 | 0.003 | 0.002 | 0 |
額外實收資本 | 652.276 | 601.523 | 579.755 | 484.372 | 0.002 |
留存收益(累計赤字) | -727.093 | -529.37 | -385.487 | -256.419 | -1.288 |
總負債和股東權益 | 164.81 | 189.431 | 295.111 | 257.178 | 0.902 |
已發行普通股總數 | 41.4689 | 30.5112 | 28.516 | 24.7283 | 25.8835 |
物業/廠房/設備,總計 - 淨額 | 3.494 | 2.564 | 3.359 | 1.396 | |
物業/廠房/設備,總計 - 總額 | 4.965 | 3.416 | 3.69 | 1.404 | |
累計折舊,總計 | -1.471 | -0.852 | -0.331 | -0.008 | |
長期債務的當前部分/資本租賃 | 0 | 7.353 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 226.726 | 257.718 | 139.843 | 160.512 | 197.813 |
現金和短期投資 | 213.677 | 248.847 | 129.574 | 155.385 | 196.838 |
現金等價物 | 213.677 | 248.847 | 129.574 | 155.385 | 196.838 |
預付的費用 | 12.938 | 8.76 | 10.269 | 5.127 | 0.975 |
總資産 | 236.992 | 265.039 | 144.01 | 164.81 | 201.931 |
物業/廠房/設備,總計 - 淨額 | 3.658 | 3.044 | 3.363 | 3.494 | 3.313 |
物業/廠房/設備,總計 - 總額 | 5.519 | 4.784 | 4.98 | 4.965 | 4.617 |
累計折舊,總計 | -1.861 | -1.74 | -1.617 | -1.471 | -1.304 |
其他長期資産,總計 | 6.608 | 4.277 | 0.804 | 0.804 | 0.805 |
流動負債總額 | 23.979 | 21.545 | 14.443 | 26.237 | 22.879 |
應付賬款 | 5.794 | 4.174 | 4.805 | 9.997 | 7.135 |
預提費用 | 15.794 | 17.095 | 9.638 | 16.24 | 14.799 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 2.391 | 0.276 | 0.945 | ||
負債總額 | 254.765 | 247.439 | 234.205 | 239.624 | 228.354 |
長期債務總額 | 222.658 | 217.605 | 211.317 | 204.789 | 196.728 |
長期債務 | 222.658 | 217.605 | 211.317 | 204.789 | 196.728 |
其他負債,總計 | 8.128 | 8.289 | 8.445 | 8.598 | 8.747 |
股權 | -17.773 | 17.6 | -90.195 | -74.814 | -26.423 |
普通股 | 0.005 | 0.005 | 0.004 | 0.003 | 0.003 |
額外實收資本 | 831.337 | 823.467 | 674.708 | 652.276 | 645.62 |
留存收益(累計赤字) | -849.115 | -805.872 | -764.907 | -727.093 | -672.046 |
總負債和股東權益 | 236.992 | 265.039 | 144.01 | 164.81 | 201.931 |
已發行普通股總數 | 56.7901 | 56.6391 | 43.5711 | 41.4689 | 41.1438 |
總庫存 | 0.111 | 0.111 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -197.723 | -143.883 | -129.068 | -255.131 | -1.288 |
經營活動産生的現金 | -146.53 | -148.457 | -69.688 | -36.51 | -1.023 |
非現金物品 | 31.056 | 22.22 | 7.34 | 228.135 | 0.05 |
已付現金利息 | 7.033 | 4.069 | 3.464 | 1.007 | 0 |
營運資金的變化 | 19.517 | -27.315 | 51.717 | -9.522 | 0.215 |
投資活動産生的現金 | -1.041 | -0.328 | -1.04 | -25.25 | 0 |
其他投資現金流量項目,總計 | -25.118 | 0 | |||
融資活動産生的現金 | 120.042 | 44.708 | 114.459 | 304.646 | 1.902 |
股票的發行(報廢),淨額 | 24.596 | 1.944 | 89.459 | 191.472 | 0.002 |
債務的發行(退還),淨額 | 95.446 | 42.764 | 25 | 113.174 | 1.9 |
現金淨變化 | -27.529 | -104.077 | 43.731 | 242.886 | 0.879 |
經營活動産生的現金 | 0.62 | 0.521 | 0.323 | 0.008 | |
資本支出 | -1.041 | -0.328 | -1.04 | -0.132 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -37.814 | -197.723 | -142.676 | -91.585 | -40.665 |
Cash From Operating Activities | -39.669 | -146.53 | -105.834 | -70.818 | -44.757 |
Cash From Operating Activities | 0.146 | 0.62 | 0.452 | 0.277 | 0.128 |
Non-Cash Items | 9.184 | 31.056 | 22.811 | 15.296 | 7.732 |
Cash Interest Paid | 2.546 | 7.033 | 4.938 | 2.919 | 1.388 |
Changes in Working Capital | -11.185 | 19.517 | 13.579 | 5.194 | -11.952 |
Cash From Investing Activities | -0.214 | -1.041 | -0.629 | -0.495 | -0.067 |
Capital Expenditures | -0.214 | -1.041 | -0.629 | -0.495 | -0.067 |
Cash From Financing Activities | 14.072 | 120.042 | 120.042 | 95.446 | 0 |
Issuance (Retirement) of Stock, Net | 14.072 | 24.596 | 24.596 | 0 | 0 |
Issuance (Retirement) of Debt, Net | 95.446 | 95.446 | 95.446 | ||
Net Change in Cash | -25.811 | -27.529 | 13.579 | 24.133 | -44.824 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
100 Campus Drive
Suite 102
FLORHAM PARK
NEW JERSEY 07932
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易